Pediatric Exclusivity May Overcompensate Blockbuster Products – JAMA Study

12 Feb 2007
News

Brenda Sandburg @brendasandburg Brenda.Sandburg@informa.com

Executive Summary

The net economic return to companies granted pediatric exclusivity ranged from $8.9 million to $507 million, researchers found in a study of the economic impact of the pediatric exclusivity program

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS048023

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS048023

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Pediatric Exclusivity May Overcompensate Blockbuster Products – JAMA Study

News

Executive Summary

Related Content

Pediatric Exclusivity 90-Day Review Can Be “Difficult” Target – Kweder

Pediatric Exclusivity 90-Day Review Can Be “Difficult” Target – Kweder

Pediatric Studies Become Costlier; Congress May Make Them Less Profitable

Pediatric Studies Become Costlier; Congress May Make Them Less Profitable

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert